American Cancer Society guidelines recommend yearly FIT or FOBT tests for people at least 50 years of age at average risk, as one of the recommended screening options.^1,2

• Colorectal cancer is the second leading cause of cancer death in the U.S., yet one of the few cancers that is largely curable if detected in the early stages and can even be prevented in some cases by removing polyps.
• When colorectal cancers are detected at an early stage, the five-year survival is 90%; however, only 39% of colorectal cancers are diagnosed at this stage.

According to the United States Centers for Disease Control and Prevention (CDC), up to 60% of deaths from colorectal cancer could be avoided if people over 50 received the recommended screening tests.³
An FOBT done during a digital rectal exam in the doctor’s office is not sufficient for screening and is not recommended by American Cancer Society guidelines. If your doctor performs a DRE, you should ask him or her about the InSure® FIT™ test.

The InSure® FIT™ test has demonstrated an 87% sensitivity for colorectal cancer.^5,6  FIT tests are one of the screening options recommended by the guidelines from the American Cancer Society.

Sensitivity is a measure of the ability of a test to find the disease when it is present. A highly specific test is one that rarely indicates abnormality when no abnormality is present.

Colorectal cancer screening tests are covered by most insurance plans. For more information, review your health insurance policy or discuss with your health insurance provider. 

No. You do not need to change your diet in any way before using the InSure® FIT™ test. Unlike traditional guaiac-based FOBTs, you don’t need to avoid any foods before using this test.

No. Unlike the traditional guaiac-based take-home FOBTs, you do not need to change any medications or medication routines.

No! The InSure® FIT™ test with the patented long-handled blue brush, allow you to perform the screening test with no fecal handling or smearing. After each of two different bowel movements, use the patented long handled blue brush to gently brush the surface of the stool in water for about 5 seconds, and then dab it onto the test card.  We call this the Blue Brush Method!

Because colorectal conditions may not bleed all the time, or blood may not be uniformly distributed in the stool, multiple sample FOBT or FIT take-home tests are recommended by the American Cancer Society (ACS) as one of the screening options. A single FOBT done during a digital rectal exam in the doctor’s office is not sufficient for screening and is not recommended by the ACS.  The InSure® FIT™  test requires one sample from two different bowel movements.

With the InSure® FIT™  test, the sampling procedure is more user-friendly. Unlike traditional guaiac-based FOBTs and some other FIT tests, the patented InSure® FIT™ brush requires no fecal handling, and requires only two samples. Because InSure® FIT™ test detect human hemoglobin from blood, there are no drug or dietary restrictions required to complete the test.

Unlike the InSure® FIT™ test, stool DNA tests require patients to pack an entire bowel movement in a kit and send the sample to a laboratory for testing. InSure® FIT™ tests are more convenient and easier-to-use than sDNA tests because of their unique Blue Brush Method for sample collection. After each of two different bowel movements, the patient uses the patented long-handled blue brush to gently brush the surface of the stool in water for about 5 seconds, and then dab it onto the test card. 

No. You should not use InSure® FIT™  test if you see blood in the toilet bowl. If you see blood in the toilet bowl, you should immediately consult your physician.

No. You should not use the InSure® FIT™ test if you have any hemorrhoids that are actively bleeding. Because the InSure® FIT™  screening test detects blood in and around the stool, active bleeding from hemorrhoids could provide a false positive test result.

No. You should not perform the test three days before, during, or three days after your menstrual period.  Because the InSure® FIT™  screening test detects blood in and around the stool, active bleeding from menstruation could provide a false positive test result.

You can perform the test if someone else in the house is menstruating, provided that you flush the toilet before beginning your sample collection process.

Not necessarily. A positive test only indicates that blood was detected in the samples collected. This blood may be from conditions other than colorectal cancer. If you have a positive result, we strongly urge you to discuss the findings with your physician to establish the source of the bleeding and determine treatment, if appropriate.  In general, a further test of the colon and rectum (such as a colonoscopy) may be required.